Skip to content

Psychological treatment for depression in aphasic stroke patients: a randomised controlled trial

Psychological treatment for depression in aphasic stroke patients: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN63855912
Enrollment
180
Registered
2006-09-29
Start date
2005-04-01
Completion date
Unknown
Last updated
2019-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental and Behavioural Disorders: Depression Mental and Behavioural Disorders Depression

Interventions

This study uses a randomised controlled trial design (RCT). In this RCT aphasic patients with low mood will be randomly allocated to one of three groups: behavioural psychotherapy, attention placebo,

Sponsors

Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: It is intended that 180 patients will be recruited, one-third (60) of these will be randomly allocated to a control group (no intervention group). Stroke patients with aphasia will be eligible for inclusion in the study. They will have been referred to the Speech & Language Therapists (SALT) in Nottingham with aphasia.

Exclusion criteria

Exclusion criteria: 1. Patients will be excluded form the study if they are blind or deaf as it will not be practical to administer the assessments using standardised methods with these patients. These patients are still important, but a future study would be required to determine how assessments and therapies could be adapted for patients with severe vision and hearing problems. 2. Patients with dementia documented in their medical notes will be excluded as these patients may not have a reliable insight into their mood and the difficulties they face following their stroke. 3. Patients who received treatment for depression in the 5 years prior to their stroke will also be excluded as this study is concerned with patients who become depressed after their stroke. 4. Patients who live more than 40 miles from the recruiting centre will be excluded as it will not be practical for the researchers and therapist to visit these patients.

Design outcomes

Primary

MeasureTime frame
The primary outcome measures will be completed at 3 months and 6 months after randomisation to assess mood: Visual Analogue Mood Scales (VAMS) and Stroke Aphasic Depression Questionnaire (SADQ).

Secondary

MeasureTime frame
The secondary outcome measures will be completed at 3 months and 6 months after randomisation to assess any change in activity level: Extended Activities of Daily Living Scale (EADL) and Nottingham Leisure Questionnaire.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026